Stocks and Investing Stocks and Investing
Thu, November 4, 2021
[ 12:00 AM ] - WOPRAI
David Hynes Maintained (UPLD) at Strong Buy with Decreased Target to $35 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
William Crow Maintained (XHR) at Buy with Increased Target to $21 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Tejas Savant Maintained (TXG) at Buy with Decreased Target to $205 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Drew Crum Maintained (TTWO) at Strong Buy with Increased Target to $232 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Colin Sebastian Maintained (TTWO) at Buy and Held Target at $215 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Mario Lu Maintained (TTWO) at Buy and Held Target at $220 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Justin Patterson Maintained (TTGT) at Buy with Increased Target to $115 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Aaron Kessler Maintained (TTGT) at Buy with Increased Target to $112 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Tommy Moll Maintained (TT) at Hold with Increased Target to $205 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Deane Dray Maintained (TT) at Hold with Decreased Target to $183 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Joshua Pokrzywinski Maintained (TT) at Buy with Increased Target to $217 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Nicole Deblase Maintained (TT) at Hold with Increased Target to $193 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Stephen Gengaro Maintained (WHD) at Strong Buy with Increased Target to $51 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Samuel Eisner Maintained (WHR) at Strong Buy and Held Target at $280 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
David George Maintained (WFC) at Buy and Held Target at $50 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Andrew Charles Maintained (WING) at Buy with Decreased Target to $175 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Christopher Carril Maintained (WING) at Hold with Decreased Target to $158 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Sean Horgan Maintained (VIRT) at Strong Buy with Increased Target to $38 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Rommel Dionisio Maintained (VSTO) at Strong Buy with Increased Target to $57 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Steven Delaney Maintained (ACRE) at Buy and Held Target at $17 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Neal Dingmann Upgraded (APA) to Strong Buy and Increased Target to $45 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Pearce Hammond Downgraded (AMRC) to Hold and Increased Target to $96 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
John Heagerty Downgraded (AON) to Hold and Held Target at $320 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Ben Bienvenu Upgraded (ANDE) to Buy and Increased Target to $48 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Justin Patterson Maintained (ANGI) at Buy with Decreased Target to $16 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Brent Thill Downgraded (ASAN) to Hold and Increased Target to $135 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Michael Cyprys Maintained (APO) at Buy with Increased Target to $90 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Gena Wang Maintained (BCRX) at Buy with Decreased Target to $17 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Brian Abrahams Maintained (BCRX) at Hold with Decreased Target to $14 on, Nov 4th, 2021
[ 12:00 AM ] - WOPRAI
Michael King Maintained (AGIO) at Strong Buy with Increased Target to $95 on, Nov 4th, 2021

Michael King Maintained (AGIO) at Strong Buy with Increased Target to $95 on, Nov 4th, 2021


Published on 2024-10-27 18:30:39 - WOPRAI, Michael King
  Print publication without navigation


Michael King of HC Wainwright & Co., Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Strong Buy with Increased Target from $93 to $95 on, Nov 4th, 2021.

Michael has made no other calls on AGIO in the last 4 months.



There is 1 other peer that has a rating on AGIO. Out of the 1 peers that are also analyzing AGIO, 0 agree with Michael's Rating of Hold.



This is the rating of the analyst that currently disagrees with Michael

  • Salveen Richter of "Goldman Sachs" Downgraded from Hold to Strong Sell and Decreased Target to $39 on, Friday, July 30th, 2021
Contributing Sources